<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01332877</url>
  </required_header>
  <id_info>
    <org_study_id>0029-11-WOMC</org_study_id>
    <nct_id>NCT01332877</nct_id>
  </id_info>
  <brief_title>Breakfast Size and Weight Loss in Overweight/Obese Adults</brief_title>
  <official_title>The Effect of Breakfast Enriched With Protein and Carbohydrates on Weight Loss, Hunger, Satiety and Ghrelin in Overweight and Obese Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      EFFECT OF HIGH CARBOHYDRATE AND HIGH PROTEIN BREAKFAST ON WEIGHT LOSS, GHRELIN, HUNGER AND
      CRAVING SCORES IN OBESE MEN AND WOMEN. D Jakubowicz, M Boaz, J Wainstein, O Froy

      Background: Obesity underlying endocrine, metabolic and eating behaviour features promotes
      weight gain, increase of hunger, and carbohydrate (Carb) craving. Restrictive diets either in
      calories or Carb produce withdrawal effect, that further exacerbate Carb craving resulting in
      rapid return of obesity. Meal timing and composition has shown to play a pivotal role in
      appetite regulation through several hormonal systems such as ghrelin. The investigators
      hypothesized that to be successful; a weight loss strategy must change the hormonal
      environment to increase satiety while reducing hunger and craving.

      Objectives: To assess weight loss, satiety, hunger, cravings and ghrelin response to two
      isocaloric diets. Additionally, these outcomes were measured in response to meal challenge.

      Methods: In this randomized, treatment controlled clinical trial, 146 obese, sedentary adults
      with impaired glucose tolerance will be assigned to Low carb diet (LCHbd) or an isocaloric
      diet with a high carb, high protein breakfast (HCPbd),1400 kcal for women and 1600 kcal for
      men. LCHbd breakfast will provide 300 kcal with carb: protein: fat of 13:40:48. HCPbd
      breakfast will provide 600 kcal with 50:20:30. From baseline until week 16 participants will
      take part in a supervised weight loss diet, followed until week 32 by a maintenance period.
      Anthropometric measures, OGTT for glucose and insulin, VAS-measured hunger and satiety and
      Food Craving Inventory Analysis will be performed at baseline, week 16 and week 32.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <primary_completion_date type="Anticipated">November 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>32 weeks</time_frame>
    <description>Change from baseline weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hunger</measure>
    <time_frame>32 weeks</time_frame>
    <description>VAS hunger scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satiety</measure>
    <time_frame>32 weeks</time_frame>
    <description>VAS satiety scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma ghrelin</measure>
    <time_frame>32 weeks</time_frame>
    <description>change from baseline ghrelin</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>enriched breakfast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high carbohydrate, high protein breakfast providing 600 kcal, 50% carbohydrate, 20% protein, 30% fat</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enriched breakfast</intervention_name>
    <description>high carbohydrate, high protein breakfast supplying 600 kcal as 50k% carbohydrate, 20% protein, 30% fat</description>
    <arm_group_label>enriched breakfast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control breakfast</intervention_name>
    <description>Control breakfast providing 300 kcal, 13% carbohydrate, 40% protein, 48% fat</description>
    <arm_group_label>enriched breakfast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult

          -  male and female

          -  obese

          -  sedentary

          -  glucose intolerant/insulin resistant

        Exclusion Criteria:

          -  pregnant/lactating

          -  malignancy

          -  taking weight loss medications

          -  know eating disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniela Jakubowicz, MD</last_name>
    <phone>972-50-810-5552</phone>
    <email>daniela.jak@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julio Wainstein, MD</last_name>
    <phone>972-3-502-8716</phone>
    <email>vainstein@wolfson.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <zip>58100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Jakubowicz, MD</last_name>
      <phone>972-50-810-5552</phone>
      <email>daniela.jak@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Daniela Jakubowicz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2011</study_first_submitted>
  <study_first_submitted_qc>April 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2011</study_first_posted>
  <last_update_submitted>April 8, 2011</last_update_submitted>
  <last_update_submitted_qc>April 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Daniel Jakubowicz</name_title>
    <organization>E. Wolfson Medical Center</organization>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Weight loss</keyword>
  <keyword>Ghrelin</keyword>
  <keyword>Satiety</keyword>
  <keyword>Hunger</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

